Abstract:High-grade gliomas are the most aggressive malignant brain tumors. Accurate pre-operative prognosis for this cohort can lead to better treatment planning. Conventional survival prediction based on clinical information is subjective and could be inaccurate. Recent radiomics studies have shown better prognosis by using carefully-engineered image features from magnetic resonance images (MRI). However, feature engineering is usually time consuming, laborious and subjective. Most importantly, the engineered features cannot effectively encode other predictive but implicit information provided by multi-modal neuroimages. We propose a two-stage learning-based method to predict the overall survival (OS) time of high-grade gliomas patient. At the first stage, we adopt deep learning, a recently dominant technique of artificial intelligence, to automatically extract implicit and high-level features from multi-modal, multi-channel preoperative MRI such that the features are competent of predicting survival time. Specifically, we utilize not only contrast-enhanced T1 MRI, but also diffusion tensor imaging (DTI) and resting-state functional MRI (rs-fMRI), for computing multiple metric maps (including various diffusivity metric maps derived from DTI, and also the frequency-specific brain fluctuation amplitude maps and local functional connectivity anisotropy-related metric maps derived from rs-fMRI) from 68 high-grade glioma patients with different survival time. We propose a multi-channel architecture of 3D convolutional neural networks (CNNs) for deep learning upon those metric maps, from which high-level predictive features are extracted for each individual patch of these maps. At the second stage, those deeply learned features along with the pivotal limited demographic and tumor-related features (such as age, tumor size and histological type) are fed into a support vector machine (SVM) to generate the final prediction result (i.e., long or short overall survival time). The experimental results demonstrate that this multi-model, multi-channel deep survival prediction framework achieves an accuracy of 90.66%, outperforming all the competing methods. This study indicates highly demanded effectiveness on prognosis of deep learning technique in neuro-oncological applications for better individualized treatment planning towards precision medicine.

Laryngeal candidiasis presenting as inspiratory stridor.

SurvNet: A low-complexity convolutional neural network for survival time classification of patients with glioblastoma

Multi-Channel 3D Deep Feature Learning for Survival Time Prediction of Brain Tumor Patients Using Multi-Modal Neuroimages

Predicting cancer outcomes from histology and genomics using convolutional networks

PathoGraph: An Attention-Based Graph Neural Network Capable of Prognostication Based on CD276 Labelling of Malignant Glioma Cells

Artificial intelligence neuropathologist for glioma classification using deep learning on hematoxylin and eosin stained slide images and molecular markers

Prediction of overall survival and molecular markers in gliomas via analysis of digital pathology images using deep learning

Classifying Subtypes and Predicting Survival of Renal Cell Carcinoma Using Histopathology Image-Based Deep Learning

Deep learning-based survival prediction for multiple cancer types using histopathology images

Effect of the addition of bird repellents to aerially applied 1080 baits on rat and possum abundance

Harnessing Deep Learning for Accurate Pathological Assessment of Brain Tumor Cell Types

Thyrotropin (TSH)-releasing hormone stimulation test responses employing third and fourth generation TSH assays.

Neurovirulence safety testing of mumps vaccines--historical perspective and current status.

Interpretable Classification from Skin Cancer Histology Slides Using Deep Learning: A Retrospective Multicenter Study

Prognostic analysis of histopathological images using pre-trained convolutional neural networks: application to hepatocellular carcinoma

Deep neural networks integrating genomics and histopathological images for predicting stages and survival time-to-event in colon cancer

Histopathological Image Classification of Breast Cancer using EfficientNet

NIMG-60. PREDICTING OVERALL SURVIVAL IN GLIOBLASTOMA USING HISTOPATHOLOGY VIA AN END-TO-END DEEP LEARNING PIPELINE: A LARGE MULTI-COHORT STUDY

Deep Learning versus Classical Regression for Brain Tumor Patient Survival Prediction

Comparative Analysis of Different Deep Convolutional Neural Network Architectures for Classification of Brain Tumor on Magnetic Resonance Images

Deep learning-based breast cancer grading and survival analysis on whole-slide histopathology images